Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Jun;21(6):919–924. doi: 10.1128/aac.21.6.919

Effect of ketoconazole on isolated mitochondria from Candida albicans.

M L Shigematsu, J Uno, T Arai
PMCID: PMC182046  PMID: 6287930

Abstract

Ketoconazole, an oral antimycotic imidazole drug, blocked the transport of electrons in the respiratory chain of Candida albicans under aerobic conditions with different substrates, such as NADH and succinate. This effect was a nonspecific inhibition of NADH oxidases and succinate oxidases. The addition of ketoconazole to C. albicans mitochondria without a substrate resulted in strong reduction of cytochrome a3, as revealed by difference spectra (reduced versus oxidized). This indicated that there was a specific interaction between ketoconazole and cytochrome c oxidase. A spectrophotometric analysis confirmed that the cytochrome oxidases other than cytochrome c oxidase were not inhibited because subsequent addition of any substrate caused an increased level of reduction of all of the other respiratory chain components compared with the control. Consequently, our data strongly suggested that the primary site of ketoconazole inhibition on isolated mitochondria from C. albicans is the most distal portion of the respiratory chain.

Full text

PDF
919

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Nollin S., Van Belle H., Goossens F., Thone F., Borgers M. Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother. 1977 Mar;11(3):500–513. doi: 10.1128/aac.11.3.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dixon D., Shadomy S., Shadomy H. J., Espinel-Ingroff A., Kerkering T. M. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. J Infect Dis. 1978 Aug;138(2):245–248. doi: 10.1093/infdis/138.2.245. [DOI] [PubMed] [Google Scholar]
  3. Drouhet E., Dupont B. Chronic mucocutaneous candidosis and other superficial and systemic mycoses successfully treated with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):606–619. doi: 10.1093/clinids/2.4.606. [DOI] [PubMed] [Google Scholar]
  4. ESTABROOK R. W. Studies of oxidative phosphorylation with potassium ferricyanide as electron acceptor. J Biol Chem. 1961 Nov;236:3051–3057. [PubMed] [Google Scholar]
  5. Henry M. F., Nyns E. D. Cyanide-insensitive respiration. An alternative mitochondrial pathway. Subcell Biochem. 1975 Mar;4(1):1–65. [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Levine H. B., Cobb J. M. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole. Am Rev Respir Dis. 1978 Oct;118(4):715–721. doi: 10.1164/arrd.1978.118.4.715. [DOI] [PubMed] [Google Scholar]
  8. Norling B., Nelson B. D., Nordenbrand K., Ernster L. Evidence for the occurrence in submitochondrial particles of a dual respiratory chain containing different forms of cytochrome b. Biochim Biophys Acta. 1972 Jul 12;275(1):18–32. doi: 10.1016/0005-2728(72)90021-7. [DOI] [PubMed] [Google Scholar]
  9. Ohnishi T., Kawaguchi K., Hagihara B. Preparation and some properties of yeast mitochondria. J Biol Chem. 1966 Apr 25;241(8):1797–1806. [PubMed] [Google Scholar]
  10. PENNINGTON R. J. Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J. 1961 Sep;80:649–654. doi: 10.1042/bj0800649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Restrepo A., Stevens D. A., Gómez I., Leiderman E., Angel R., Fuentes J., Arana A., Mejía G., Vanegas A. C., Robledo M. Ketoconazole: a new drug for the treatment of paracoccidioidomycosis. Rev Infect Dis. 1980 Jul-Aug;2(4):633–642. doi: 10.1093/clinids/2.4.633. [DOI] [PubMed] [Google Scholar]
  12. Shepherd M. G., Chin C. M., Sullivan P. A. The alternate respiratory pathway of Candida albicans. Arch Microbiol. 1978 Jan 23;116(1):61–67. doi: 10.1007/BF00408734. [DOI] [PubMed] [Google Scholar]
  13. Sud I. J., Feingold D. S. Heterogeneity of action of mechanisms among antimycotic imidazoles. Antimicrob Agents Chemother. 1981 Jul;20(1):71–74. doi: 10.1128/aac.20.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Uno J., Shigematsu M. L., Arai T. Primary site of action of ketoconazole on Candida albicans. Antimicrob Agents Chemother. 1982 Jun;21(6):912–918. doi: 10.1128/aac.21.6.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Williams D. M., Graybill J. R., Drutz D. J., Levine H. B. Suppression of cryptococcosis and histoplasmosis by ketoconazole in athymic nude mice. J Infect Dis. 1980 Jan;141(1):76–80. doi: 10.1093/infdis/141.1.76. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES